Fondazione Cariverona:“Development and validation of a novel molecular assay forα-synuclein in patients with Parkinson’s disease and otherα-synucleinopathies”#2018.0708 to GZ and Brain Research Verona Foundation to GZ.Dr.Elena Fontana is attending a doctoral fellowship supported by COPAN group.
Background: In patients with Parkinson’s disease (PD), real-time quaking-induced conversion (RT-QuIC) detection of pathological α-synuclein (α-syn) in olfactory mucosa (OM) is not as accurate as in other α-synucle...
Intramural funding of the Dept.of Neurology,Kiel University.
Background:IgG-class autoantibodies to N-Methyl-D-Aspartate(NMDA)-type glutamate receptors define a novel entity of autoimmune encephalitis.Studies examining the prevalence of NMDA IgA/IgM antibodies in patients with ...
This work was supported by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health(NINDS R03 NS09324501A1 and NINDS/NIH 1R21NS087235-01A1 to to X.G.).
Evidence from epidemiological studies suggest a relationship between cigarette smoking and low risk of Parkinson disease(PD).As a major component of tobacco smoke,nicotine has been proposed to be a substance for preve...
This review was supported by research grants from the State Key Development Program for Basic Research of China(2011CB510000);the National Natural Science Foundation of China(81271428,81471292,U1503222 and 81430021);the keypoint Science Foundation of Guangdong of China(2015A030311021);a grant supported by technology project of Guangzhou(201604020152);a grant supported by assisting research project of science and technology for Xinjiang(201591160).
Parkinson’s disease(PD)is referring to the multi-systemicα-synucleinopathy with Lewy bodies deposited in midbrain.In ageing,the environmental and genetic factors work together and overactive major histocompatibility...